Journal article · 2025 · Open access

Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline

Magdalena Madero, Adeera Levin, Sofia Bano Ahmed, Juan Jesús Carrero, Bethany Joy Foster, Anna Francis, Rasheeda K. Hall, William Guy Herrington, Guy Hill, Lesley A. Inker, Rümeyza Kazancıoğlu, Edmund J. Lamb and 21 more

Annals of Internal Medicine, 178(5), 705–713 · Published 10 March 2025 · DOI 10.7326/annals-24-01926

Free PDFView at the publisherCite this paper

In brief

“Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline” is a 2025 journal article by Magdalena Madero and 32 co-authors, published in Annals of Internal Medicine. OpenAlex counts 82 citations as of 15 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access: the full text is free to read at Oxford University Research Archive (ORA) (University of Oxford).

Citations
82
Most cited in
2026 (62)
Field-weighted impact
44.99
References
59
Authors
33

Abstract

DESCRIPTION: The Kidney Disease: Improving Global Outcomes (KDIGO) organization updated its existing clinical practice guideline in 2024 to provide guidance on the evaluation, management, and treatment of chronic kidney disease (CKD) in adults and children who are not receiving kidney replacement therapy. METHODS: The KDIGO CKD Guideline Work Group defined the scope of the guideline and determined topics for systematic review. An independent Evidence Review Team systematically reviewed the evidence and graded the certainty of evidence for each of the review topics. Latest searches of the English-language literature were done in July 2023. Final modification of the guideline was informed by a public review process during summer of 2023 involving registered stakeholders. RECOMMENDATIONS: The full guideline included 28 recommendations and 141 practice points. This synopsis focuses on the recommendations that have the greatest evidence. Practice points reflect the expert opinion of the group where evidence is not that strong. Recommendations include greater emphasis on cystatin C for assessment of glomerular filtration rate, point-of-care testing in remote areas, a shift to an individualized risk-based approach to predict kidney failure, sodium-glucose cotransporter-2 inhibitors for some patients with CKD with and without diabetes, and statin use for adults older than 50 years and CKD. Together the recommendations and practice points provide guidance for how to evaluate and manage persons with CKD.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Madero, M., Levin, A., Ahmed, S. B., Carrero, J. J., Foster, B. J., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., Lamb, E. J., Lin, P., McIntyre, N. J., Morrow, K. J., Roberts, G. V., Sabanayagam, D., Shlipak, M. G., Shroff, R. C., . . . Schäeffner, E. (2025). Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline. Annals of Internal Medicine, 178(5), 705–713. https://doi.org/10.7326/annals-24-01926

MLA 9

Madero, Magdalena, et al. “Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline.” Annals of Internal Medicine, vol. 178, no. 5, 2025, pp. 705–713. https://doi.org/10.7326/annals-24-01926.

Chicago

Madero, Magdalena, Adeera Levin, Sofia Bano Ahmed, Juan Jesús Carrero, Bethany Joy Foster, Anna Francis, Rasheeda K. Hall, et al. 2025. “Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline.” Annals of Internal Medicine 178 (5): 705–713. https://doi.org/10.7326/annals-24-01926.

Harvard

Madero, M. et al. (2025) ‘Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline’, Annals of Internal Medicine, 178(5), pp. 705–713. doi:10.7326/annals-24-01926.

IEEE

M. Madero et al., “Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline,” Annals of Internal Medicine, vol. 178, no. 5, pp. 705–713, 2025, doi: 10.7326/annals-24-01926.

BibTeX

@article{madero2025evaluation,
  title     = {{Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline}},
  author    = {Madero, Magdalena and Levin, Adeera and Ahmed, Sofia Bano and Carrero, Juan Jesús and Foster, Bethany Joy and Francis, Anna and Hall, Rasheeda K. and Herrington, William Guy and Hill, Guy and Inker, Lesley A. and Kazancıoğlu, Rümeyza and Lamb, Edmund J. and Lin, Peter and McIntyre, Natasha J. and Morrow, Kelly J. and Roberts, Glenda V. and Sabanayagam, Dharshana and Shlipak, Michael G. and Shroff, Rukshana C. and Tangri, Navdeep and Thanachayanont, Teerawat and Ulasi, Ifeoma and Wong, Germaine and Yang, Chih‐Wei and Zhang, Luxia and Robinson, Karen A. and Wilson, Lisa M and Wilson, Renée F and Kasiske, B.L. and Cheung, Michael and others},
  journal   = {Annals of Internal Medicine},
  year      = {2025},
  volume    = {178},
  number    = {5},
  pages     = {705--713},
  doi       = {10.7326/annals-24-01926},
  url       = {https://doi.org/10.7326/annals-24-01926}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes

  • chronic kidney disease
  • glomerular filtration rate estimation
  • cystatin C
  • point-of-care testing
  • kidney failure risk prediction
  • SGLT2 inhibitors
  • statins
  • CKD management

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Madero, M., Levin, A., Ahmed, S. B., Carrero, J. J., Foster, B. J., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., Lamb, E. J., Lin, P., McIntyre, N. J., Morrow, K. J., Roberts, G. V., Sabanayagam, D., Shlipak, M. G., Shroff, R. C., . . . Schäeffner, E. (2025). Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline. Annals of Internal Medicine, 178(5), 705–713. https://doi.org/10.7326/annals-24-01926

How many times has this paper been cited?

82 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Oxford University Research Archive (ORA) (University of Oxford).

Who wrote this paper?

Magdalena Madero, Adeera Levin, Sofia Bano Ahmed, Juan Jesús Carrero, Bethany Joy Foster, Anna Francis, Rasheeda K. Hall, William Guy Herrington, Guy Hill, Lesley A. Inker, Rümeyza Kazancıoğlu, Edmund J. Lamb and 21 more.

What is the DOI of this paper?

10.7326/annals-24-01926. The permanent link is https://doi.org/10.7326/annals-24-01926.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.